George Cavanagh
Family Medicine · Bowie, MDNPI 1477554293
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,582 and has fallen 67.7% since, to $511 in 2022.
Across 142 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$320
- Astellas Pharma US Inc$305
- Novo Nordisk$237
- Merck$188
- Amgen$174
- GSK$174
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,22492%
- Education$2058%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 22 | $320 |
| Astellas Pharma US Inc | 7 | $305 |
| Novo Nordisk | 14 | $237 |
| Merck | 16 | $188 |
| Amgen(2 entities) | 10 | $174 |
| GSK | 10 | $174 |
| AbbVie(2 entities) | 10 | $172 |
| Pfizer | 14 | $147 |
| Kowa Pharmaceuticals America, Inc. | 7 | $119 |
| Boehringer Ingelheim | 5 | $106 |
| Amarin Pharma, Inc. | 5 | $104 |
| Lilly USA, LLC | 6 | $95 |
| E.r. Squibb & Sons, L.L.C. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Novartis | 2 | $38 |
| Boston Scientific | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Abbott | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $17 |
| Medtronic | 1 | $15 |
| Eisai Inc. | 1 | $13 |
How this compares
$2,429 in reported general payments places this provider in the 80th percentile of 1,193 family medicine providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rivastigmine | 12 | $3,688 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bowie
- Tramaine DavisBowie$43K
- Anna McCallBowie$24K
- Karen DonaldsonBaltimore$899K
- Louis JacquesBaltimore$522K
- Michael ObiefuneBaltimore$291K
- Thomas LawrenceBerlin$254K
- Casey ScottCambridge$88K
- Daljeet SalujaBaltimore$63K
- Sanjay SaxenaHagerstown$60K
- Cynthia KleppingerSilver Spring$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.